Subnormal Pancreatic Polypeptide and Epinephrine Responses to Insulin-Induced Hypoglycemia Identify Patients with Insulin-Dependent Diabetes Mellitus Predisposed to Develop Overt Autonomic Neuropathy

  1. FRANK P. KENNEDY, M.D.;
  2. VAY L. W. GO, M.D.;
  3. PHILIP E. CRYER, M.D.;
  4. GEREMIA B. BOLLI, M.D.; and
  5. JOHN E. GERICH, M.D.
  1. Rochester, Minnesota; St. Louis, Missouri
    ;
    Perugia
    , Italy; and
    Pittsburgh, Pennsylvania

    Abstract

    Sixteen patients with insulin-dependent diabetes mellitus with no current evidence of autonomic dysfunction underwent an insulin tolerance test during which plasma pancreatic polypeptide and epinephrine responses were determined. Compared to 11 age- and weight-matched nondiabetic volunteers, 9 diabetic subjects had subnormal plasma pancreatic polypeptide responses (n = 6) or plasma epinephrine responses (n = 8). When autonomic function was reassessed 2 to 3 years later by standard cardiovascular reflex tests and clinical examination, 8 of 9 diabetic subjects with subnormal hormonal responses to hypoglycemia developed either abnormal cardiovascular reflexes (6 of 9) or overt symptoms consistent with diabetic autonomic neuropathy (6 of 9), whereas none of the subjects with previously normal plasma pancreatic polypeptide and epinephrine responses did (P < 0.01). Diminished pancreatic polypeptide and epinephrine responses to hypoglycemia can predict the development of overt autonomic neuropathy in patients with insulin-dependent diabetes mellitus; identification of patients with a predilection to develop autonomic neuropathy may permit earlier treatment.

    Article and Author Information

    • ▸ From the Endocrine Research Unit, Mayo Clinic and Mayo Medical School, Rochester, Minnesota; Department of Medicine, Washington University School of Medicine, St. Louis, Missouri; Instituto di Patologia Medica, Universita di Perugia, Perugia, Italy; and the Departments of Medicine and Physiology, University of Pittsburgh, Pittsburgh, Pennsylvania.

    • Grant support: in part by grants AM-20411, AM-07352, RR-00585, AM-27085, AM-20579, and RR-00036 from the U., S. Public Health Service; grant n. 86,00021,,04 from the Consiglio Nazionale delle Richerche; and the Mayo Foundation. Dr. Kennedy was the recipient of a National Research Science Award from the National Institutes of Health.

    • ▸Requests for reprints should be addressed to Frank P. Kennedy,, M.D.; Endocrine Research Unit, , , Mayo Clinic and Mayo Medical School; Rochester, , MN 55901.

    « Previous | Next Article »Table of Contents